metabolic disease therapeutics (DARA)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namemetabolic disease therapeutics (DARA)
Drug Alias Namemetabolic disease therapeutics (Signum)SGP-301SGP-401SGP-101
ClassificationSmall molecules
Mechanisms of ActionLeptin metabolism modulatorsInsulin sensitizers
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFortovia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFortovia Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A